Reno- and cardioprotective molecular mechanisms of SGLT2 inhibitors beyond glycemic control: from bedside to bench

Post time 2024-4-23 19:10:25

journal：American Journal of Physiology-Cell Physiology

Authors：Xin Chen; Carl-Friedrich Hocher; Linghong Shen; Bernhard K. Kramer; Berthold Hocher

Published date：2023-9-1

DOI：10.1152/ajpcell.00177.2023

PDF link：https://journals.physiology.org/ ... /ajpcell.00177.2023

Article link：http://dx.doi.org/10.1152/ajpcell.00177.2023

Article Source：American Physiological Society。

Remark：

Post time 2024-4-23 19:10:26

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Other] Reno- and cardioprotective molecular mechanisms of SGLT2 inhibitors beyond glycemic control: from bedside to bench

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Reno- and cardioprotective molecular mechanisms of SGLT2 inhibitors beyond glycemic control: from bedside to bench Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Reno- and cardioprotective molecular mechanisms of SGLT2 inhibitors beyond glycemic control: from bedside to bench